Skip to main content
Clinical Trials/ITMCTR2200006668
ITMCTR2200006668
Not yet recruiting
Phase 2

Exploring the Optimal Diagnosis and Treatment Strategy of Traditional Chinese Medicine Preparation Sangqi Qingxuan Ointment For Prevention and Treatment of Prehypertension and Grade 1 Hypertension:Based on the Regulation of Autonomic Nerve Function

China-Japan Friendship Hospital0 sitesTBD
Conditionshypertension

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
hypertension
Sponsor
China-Japan Friendship Hospital
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
China-Japan Friendship Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Understand the process of this trial, participate voluntarily and sign the informed consent
  • 2\. Meet the diagnostic criteria for primary hypertension grade 1 or prehypertension
  • 3\. In line with the TCM dialectical diagnosis of Yin deficiency of liver and kidney and/or hyperactivity of liver Yang and mutual junction of phlegm and blood stasis
  • 4\. No combined use of any western antihypertensive drugs
  • 5\. Age between 18 and 70

Exclusion Criteria

  • 1\. Those who cannot cooperate
  • 2\. Patients with secondary hypertension
  • 3\. Abnormal liver function, ALT, AST is more than 2 times the upper limit of normal
  • 4\. Kidney damage, blood creatinine greater than 133mmol/L
  • 5\. Patients with severe chronic gastrointestinal diseases
  • 6\. Active myocarditis or pericarditis
  • 7\. Unstable angina within 2 weeks
  • 8\. Planned cardiac surgery
  • 9\. Patients with significant hematologic disorders
  • 10\. Allergic to the test drug

Outcomes

Primary Outcomes

Not specified

Similar Trials